Health Experts Criticize EPA ’s Asbestos Draft Risk Evaluation
Doctors, scientists and occupational health experts from across the country are openly criticizing the U.S. Environmental Protection Agency’s recent asbestos draft risk evaluation. At a virtual press conference arranged by the Asbestos Disease Awareness Organization last week, speakers labeled the asbestos evaluation inadequate and in need of serious revision. The year-long evaluation was required as part of the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was passed in 2016. It amended the original Toxic Substances Control Act, the country’s primary chemicals management law. “I am concerned that the draft has serious omissions and does not reflect the full magnitude of the dangers of asbestos exposure,” said Dr. Jacqueline Moline, a specialist in occupational and environmental medicine at Hofstra University/Northwell Health in New York. The EPA’s Science Advisory Committee on Chemicals will review the draft during meetings June 8-11. It is the next step toward the final risk evaluation of asbestos, the ninth of the first 10 substances and chemicals to undergo increased scrutiny as part of the amended TSCA. The EPA will then have the option of proposing regulations to further prohibit or limit the use, manufacture, processing or distribution of the toxic mineral. It also could recommend an outright ban of asbestos. The Science Advisory Committee on Chemicals review was originally scheduled for April 27-30, but was delayed...
U.S. District Court Judge Robert Pittman has ordered a hearing for July 22 regarding a lawsuit filed by Texas bar and nightclub owners fighting the state order that closed their doors due to the Covid-19 pandemic. The Texas Bar&Nightclub Alliance filed the federal lawsuit on behalf of its members on June 30 — four days after Gov. Gregg Abbott took executive action mandating that such establishments temporarily close, except for delivery and takeout. Plaintiffs have sought a temporary restraining…
Publication date: 15 September 2020Source: Life Sciences, Volume 257Author(s): Tapan Behl, Ishnoor Kaur, Simona Bungau, Arun Kumar, Md Sahab Uddin, Chanchal Kumar, Giridhari Pal, Sahil, Kamal Shrivastava, Gokhan Zengin, Sandeep Arora
[The Conversation Africa] COVID-19 continues to infect millions of people as the death toll mounts. There is currently no cure which means that controlling this disease requires a multi-pronged approach. This includes personal protection such as masks, social distancing and the isolation of infected individuals and their contacts.
Publication date: Available online 12 July 2020Source: Biochimica et Biophysica Acta (BBA) - General SubjectsAuthor(s): Sumit Sahni, Christoph Krisp, Mark P. Molloy, Christopher Nahm, Sarah Maloney, Josef Gillson, Anthony J. Gill, Jaswinder Samra, Anubhav Mittal
Analyst, 2020, Accepted Manuscript DOI: 10.1039/D0AN01011A, PaperXiaonan Gao, Congcong Zhao, Keyan Wei, Bo Hu, Yu-Qin Chen, Kehua Xu, Bo Tang The anticancer mechanism for reduced/oxidized ascorbic acid (AA/DHA) is of great significance for clinical cancer therapies. A pH controlled fluorescent nanocarrier was designed to targetable deliver AA and DHA into... The content of this RSS Feed (c) The Royal Society of Chemistry
Publication date: October 2020Source: Technological Forecasting and Social Change, Volume 159Author(s): A.K.M. Najmul Islam, Samuli Laato, Shamim Talukder, Erkki Sutinen
Authors: Noda Y PMID: 32652489 [PubMed - as supplied by publisher]
[SAnews.gov.za] While the country will remain on lockdown level 3 amid a rapid rise in COVID-19 infections, President Cyril Ramaphosa has announced drastic measures in an effort to preserve lives and limit the rise in infections.
Cancer therapies could potentially be more effective if their development took into account the cells that give rise to tumor-fighting cells.
A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.
More News: Asbestosis | Cancer | Cancer & Oncology | Chemistry | Conferences | COVID-19 | Environmental Health | International Medicine & Public Health | Kidney Cancer | Legislation | Lung Cancer | Mesothelioma | Occupational Health | Ovarian Cancer | Ovaries | Pandemics | Science | Toxicology | Urology & Nephrology